Home » Archive by Category "News"

Cetya Therapeutics Announces Advanced Industries Award

  $170,000 Colorado Grant will advance Cetya’s novel targeted HDAC inhibitor program. Cetya Therapeutics, Inc. announces the award of a $170,000 Advanced Industries grant from the State of Colorado to support the development of its proprietary receptor ligand-targeted histone deacetylase

Learn More »

CSU’s Economic Impact Runs Statewide

  Spending by the university, its students, faculty and staff account for about 20 percent of the city’s sales and use tax collections, according to a 2015 economic impact study released Tuesday by the university.This analysis proves that Colorado State University

Learn More »

KromaTiD Announces Empire Oncology Partnership

  Fort Collins, CO – KromaTiD Inc. announced today that it has entered into a strategic partnership with Empire Genomics of Buffalo, NY, to provide a single, comprehensive set of genomic products and services. Targeted at oncology researchers and testing

Learn More »

VetDC Announces New TANOVEA®-CA1 Publication

  VetDC, a Colorado State University startup company, is dedicated to bringing innovative pet cancer therapeutics to market. In addition to TANOVEA-CA1 for canine lymphoma, VetDC is developing VDC-597, a novel, dual-acting PI3K/mTOR inhibitor, for multiple veterinary cancers, such as

Learn More »

State of Innovation Speaker Series Presents Dr. Tara Nealey

Estimates are that pioneering CRISPR patents will be worth hundreds of millions of dollars for patent owners. At this event, Dr. Tara Nealey of Polsinelli Law will discuss notable patent disputes, the uncertainties in the overall CRISPR patent landscape, the positioning of the surrogate

Learn More »

CSU Ventures Increases Research Involvement at CSU

  Colorado State University generated $338.4 million in research expenditures in Fiscal Year 2017, a boost of nearly 2 percent. CSU researchers were also issued a record 66 patents in that same timeframe, an indication of the university’s strength in

Learn More »

Cetya Therapeutics Announces STTR Grant Award

  Cetya Therapeutics, Inc. announces the award of a $240,000 Phase I STTR grant over a 12-month period to support the in vitro assessment of its histone deacetylase inhibitors for upregulation of fetal hemoglobin as a potential treatment modality for

Learn More »

CSU Scientist Developing Alternative to Antibiotics

  It’s estimated that by 2050, deaths from superbugs or antibiotic-resistant bacteria will lead to more fatalities than cancer. As antibiotics lose their ability to fight infection, scientists at Colorado State University have found what they hope will one day be an

Learn More »

Innosphere Brings on Dr. Ben Guiot as Chief Medical Officer

Innosphere, Colorado’s leading incubator for science and technology startups, is excited to announce that Dr. Ben Guiot will join Innosphere’s Executive in Residence program as Chief Medical Officer (CMO). As CMO, Dr. Guiot will help Innosphere staff review perspective new

Learn More »

CSUV Ambassador Program Seeking Applicants 2017-2018

  CSU Ventures, the technology transfer office for CSU, is now accepting applications for the 2017-2018 CSUV Ambassador program. The ambassador program is an exciting opportunity for graduate and post-doctoral students to gain business skills related to the commercialization of cutting

Learn More »